BSEOthers1d ago · 17 Aug 2026, 04:39 pm

Intimation of default under Para A sub- paragraph 6 Schedule III-subsequent default

Mangalam Drugs & Organics Ltd · 532637

✦ AI Summary▼ NegativeDebt Restruc.

Mangalam Drugs & Organics Ltd has defaulted on its loan obligations to Bank of Baroda and Bank of Maharashtra for a period exceeding 30 days, as per the regulations of the exchange.

Analysis Scores

Earnings Impact2/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk8/10
Balance Sheet Risk6/10
Liquidity Impact2/10
Market Sentiment2/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Mangalam Drugs & Organics Ltd - 532637 - Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure

Attachments (1)

📄

890b1afa-ac4c-47aa-bec5-6fbebe36d0b7.pdf

pdf

Download →
View document text
Mangalam Drugs and Organics Limited Regd: Office : Rupam Building, 3rd Floor, 239 P. D’Mello Road, Near G. P. 0. Mumbai - 400 00 ® 91-22-62616200 / 630/ 0878 7 @ 91-22-62619090 e CIN : 124230MH1972P(C116413 REF: MDOL/CS-SE/2026-27/023 August 17,2026 Listing Department Listing Department BSE Ltd National Stock Exchange of India 1* Floor, New Trade Wing, Limited Phiroze Jeejeebhoy Towers, “Exchange Plaza™, 5" Floor, Dalal Street, Fort, Plot No. C-1. Block G, Mumbai — 400 001 Bandra - Kurla Complex, Bandra(E), Mumbai — 400 051 Scrip Code: 532637 Symbol: MANGALAM Subject: Disclosure under Regulation 30, Part A of Schedule 111 of SEBI Listing Obligation and Disclosure Requirements) Regulation, 2015 of default on bank loan account Dear Sir/Madam, This is with reference to Regulation 30, Part A of Schedule 111 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 whereby a Listed Entity is required to make disclosure to stock exchange(s) Events which shall be disclosed without any application of the guidelines for materiality as specified in sub-regulation (4) of regulation (30) Part A (6) Default by a Listed Entity non-payment of the interest or principal amount in full on the date when the debt has become due and payable. Explanation 1: In case of revolving facilities like cash credit, an entity would be considered to be in “default’ if the outstanding balance remains continuously in excess of the sanctioned limit or drawing power, whichever is lower, for more than thirty days. In view of the said provision, Mangalam Drugs and Organics Limited (the Company) is making subsequent intimation declaring that the Company has defaulted on its loan obligations to Bank of Baroda and Bank of Maharashtra for a period exceeding 30 days, as per the regulations of your exchange. As on date, the data is given below: Sr.No | Loan Account Name of Bank Amount Overdue | Date of start of Number - Cash Rs. In Lacs as on | Default Credit A/c. No. 16/08/2026 1 60383561246 Bank of Maharashtra 951.19 17/10/2025 2 04170500000243 Bank of Baroda . 606.08 20/10/2025 We are also making arrangements to pay the overdue amount as soon as possible Kindly take the above and attachment provided by management on your records. Thanking You, Yours Faithfully, For Mangalam Drugs & Organics Limited Govardhan M. Dhoot Managing Director DIN: 01240086 Factory : at Vapi (Gujarat) India @ contactus@mangalamdrugs.com @ http://www.mangalamdrugs.com Mangalam Drugs and Organics Limited MANGALAM Regd. Office : Rupam Building, 3rd Floor, 239 P. D'Mello Road, Near G. P. 0. Mumbai - 400 001. WO WP @ 91-22-62616200 / 6300 / 8787 & 91-22-62619090 e CIN : L24230MH1972PLC116413 AocTetiISd. 17/08/2026 The Company Secretary Mangalam Drugs and Organics Ltd. Mumbai. Subject : Disclosure of subsequent default on bank loan account Dear Sir/Madam, This letter is further to our letter Dt. 16/02/2026 and to inform you that Mangalam Drugs and Organics Ltd has defaulted on its loan obligations to Bank of Baroda and Bank of Maharashtra for a period exceeding 30 days, as per the regulations of your exchange. Sr.No Loan Account Name of Bank Amount Overdue | Dateof starotf - Number - Cash Rs. In Lacs as on Default | Credit A/c. No. 16/08/2026 1 60383561246 Bank of Maharashtra 951.19 17/10/2025 04170500000243 | Bank of Baroda 606.08 20/10/2025 Kindly acknowledge the same. Thanking You, For Mangylam Drugs and Organics Ltd., Jeevan Dalvi Chief Financial Officer. Factory : at Vapi (Gujarat) India ® contactus@mangalamdrugs.com @ http://www.mangalamdrugs.com